Current progress in tuberculosis chemotherapy
Date
1980Metadata
Show full item recordAbstract
BACTERIOLOGIC BASES OF SHORT-COURSE CHEMOTHERAPY. THE PURPOSE OF TUBERCULOSIS CHEMOTHERAPY IS TO STERILIZE LESIONS QUICKLY AND COMPLETELY, AND THE DRUGS ARE USED TO AVOID THE FAILURES CAUSED BY BACTERIAL RESISTANCE AND TO AVERT RELAPSES. DESPITE THE HIGH PROPORTION OF MUTANTS RESISTANT TO DRUGS AMONG WILD STRAINS OF TUBERCLE BACILLI, SELECTION OF RESISTANT BACILLI IS EASILY AVOIDED BY APPROPRIATE COMBINATIONS OF ACTIVE DRUGS, THAT IS, DRUGS TO WHICH THE BACILLI THE SENSITIVE
Subject
Collections
Full text not available. Please contact PAHO Library using this e-mail for further instructions
Related items
Showing items related by title, author, creator and subject.
-
Bhering, Marcela; Kritski, Afrânio (2020)[ABSTRACT]. Objective. To identify clinical and demographic factors associated with unfavorable treatment outcomes in patients with primary and acquired multidrug-resistant tuberculosis (MDR-TB) in Rio de Janeiro State. ...
-
Soto Cabezas, Mirtha Gabriela; Munayco Escate, César Vladimir; Escalante Maldonado, Oscar; Valencia Torres, Eddy; Arica Gutiérrez, Johans; Yagui Moscoso, Martin Javier Alfredo (2020)[RESUMEN]. Objetivo. Describir las características clínico-epidemiológicas y el perfil de resistencia de los casos de tuberculosis extensivamente resistente (TB-XDR) diagnosticados en Perú entre los años 2013 y 2015. ...
-
Laniado-Laborín, Rafael (2017)In 2014, there were 480 000 new cases of multidrug-resistant tuberculosis (MDR-TB) around the world, but only 25% of them were diagnosed and reported. Drug resistance in TB is necessarily a laboratory diagnosis. An urgent ...